Peter Burke

Raising awareness about rare disease policy in Ireland and the EU and improving access to treatments for rare disease patients

Raise awareness around HIV Health Policy further to publication of HIV Ireland and Fast Track Cities report 'Towards A National Action Plan for HIV in Ireland'

To support policy makers to invest in programmes and policies that improve health outcomes for men and their communities.

To encourage interdepartmental collaboration on policy files relevant to the life sciences sector and to embed this in the upcoming national life sciences strategy::To include industry representation in relevant EU policymaking discussions during the EU Presidency.

Government to re-consider proposed ban on commercial sunbeds

The ISCP fully supports the objectives of facilitating professional mobility across the European Union and strengthening workforce capacity within health services. We recognise the potential value of a CTF in supporting these aims where it delivers a consistently high standard…

To highlight the importance of the new IPHA Framework Agreement on the Supply and Pricing of Medicines and to encourage its implementation by the State in the coming years::To highlight the challenge of delayed patient access to innovative medicines and the potential for…

To discuss deepening collaboration to drive life sciences competitiveness and strengthen health system resilience in Ireland and Europe

To discuss European competitiveness with the European Round Table for Industry, including life sciences investment, innovation and timely access to medicines

Share correspondence on behalf of Medicines for Ireland with relevant political representatives and stakeholders regarding the possibility of supply chain disruption due to fuel protests, ensuring that medicines can continue to be manufactured, transported, exported and supplied…

Participation in consultative forums to support the development of a National Life Science Strategy in Ireland, including the contribution of perspectives on innovation, investment, competitiveness, clinical trials and supporting better patient outcomes.

The correspondence referenced European analysis suggesting a substantial proportion of vaping products circulating within the EU may be entering through irregular or illegal channels. It warned that weak enforcement, cross-border purchasing and online sales create risks for…

The correspondence warned the Bill could push adult smokers back to cigarettes and fuel an illegal market. Over 350,000 adults vape in Ireland, with more than half having quit smoking entirely, yet the Bill would effectively ban the flavours used by 97% of adult vapers.…

This would allow for “Direct Access”, meaning the auxiliary dental worker, the Dental Hygienist, to provide preventative dental treatment within their scope of practice without the dentist's prior supervision, prior examination and indicated treatment. Direct Access would help…

Discussion related to the development of a national life sciences strategy, including policy coherence across health, enterprise and industrial policy; research and innovation capability; intellectual property protection; skills and workforce development; competitiveness and…